600351.SH
亚宝药业
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 6.78
−1.31%Margins
Gross margin
52.6%
EBITDA margin
23.0%
EBIT margin
16.7%
Net margin
14.5%
FCF margin
26.1%
11.2%
Return on equity
9.7%
Return on assets
12.7%
Return on invested capital
0.67x
Asset turnover
CNY 615.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026